A complete analysis of the development of Shanghai's hospital drug market in 2020

The HMAS medical institution market analysis system in this issue deeply deconstructs the Shanghai hospital drug market in 2020: Under the influence of the epidemic and mass procurement, how will the hospital market at all levels and categories perform in 2020?

The tertiary hospital market scale is close to 50%

According to statistics from the HMAS medical institution market analysis system, in 2020, the size of the Shanghai medical institution market will be close to 55 billion yuan.

Figure 1 Market share of different levels of hospitals in Shanghai's hospital drug market in 2020

The overall market size has declined slightly

In 2020, the size of the Shanghai hospital market has declined due to the impact of the new crown epidemic.

Figure 2 2018-2020 Shanghai hospital drug market scale and growth performance

The size of the secondary hospital market has shrunk significantly

In 2020, the growth of the market size of hospitals at all levels is very different.

Figure 3 2019-2020 Shanghai hospital drug market different levels of hospital market growth performance

The anti-tumor drug market leads the whole category

In 2020, chemical drugs accounted for 75% of the hospital drug sales market in Shanghai, and proprietary Chinese medicines and biological preparations ranked second and third, accounting for 20% and 5%, respectively.

Figure 4 The proportion of different drug categories in the Shanghai hospital drug market in 2020

From the perspective of the treatment field, under the background of the overall market growth decline in 2020, half of the drug market size in the treatment field will show a negative growth.

Figure 5 The growth rate of different therapeutic areas in the Shanghai hospital drug market in 2020